首页|期刊导航|临床肝胆病杂志|基于肠道菌群-胆汁酸轴探讨肝硬化的发病新机制及干预策略

基于肠道菌群-胆汁酸轴探讨肝硬化的发病新机制及干预策略OA

Novel pathogenesis and intervention strategies for liver cirrhosis based on the gut microbiota-bile acid axis

中文摘要英文摘要

肝硬化是多种慢性肝病进展的终末阶段,伴随严重并发症且病死率高.近年来研究表明,肠道菌群和胆汁酸代谢的交互作用(肠道菌群-胆汁酸轴)与肝硬化密切相关.本文系统综述了肠道菌群-胆汁酸轴在肝硬化进展中的作用机制,阐述了肝硬化的病理特征及对机体的危害,概述了肠道菌群-胆汁酸轴与肝硬化发生发展的关联,剖析了该轴在肝硬化病程演进中的关键调控作用,并探讨了其作为肝硬化治疗靶点的潜在应用价值,以期为探索更有效的临床干预手段提供理论依据.

Liver cirrhosis is the final stage of the progression of various chronic liver diseases,often accompanied by serious complications and high mortality rates.Recent studies have shown that the interaction between gut microbiota and bile acid metabolism(the gut microbiota-bile acid axis)is closely associated with liver cirrhosis.This article systematically reviews the mechanism of action of the gut microbiota-bile acid axis in the progression of liver cirrhosis,elaborates on the pathological features of liver cirrhosis and its harm to the body,and summarizes the association of the gut microbiota-bile acid axis with the development and progression of liver cirrhosis.It also analyzes the key regulatory role of this axis in the progression of liver cirrhosis and explores its potential application value as a therapeutic target for liver cirrhosis,in order to provide a theoretical basis for exploring more effective clinical intervention methods.

刘宁宁;崔文婷;慕淑丽;马秀珍;麦平

甘肃中医药大学第一临床医学院,兰州 730000||甘肃省人民医院消化科,兰州 730000甘肃中医药大学第一临床医学院,兰州 730000||甘肃省人民医院消化科,兰州 730000甘肃中医药大学第一临床医学院,兰州 730000||甘肃省人民医院消化科,兰州 730000甘肃省人民医院消化科,兰州 730000||兰州大学第一临床医学院,兰州 730000甘肃省人民医院消化科,兰州 730000

肝硬化胃肠道微生物组胆汁酸类

Liver CirrhosisGastrointestinal MicrobiomeBile Acid

《临床肝胆病杂志》 2026 (3)

718-725,8

甘肃省自然科学基金(21JR1RA014) Natural Science Foundation of Gansu Province(21JR1RA014)

10.12449/JCH260330

评论